Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
COLL
COLL
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
COLL News
Collegium Pharmaceutical Reports Transformative Growth in Q4 2025 Earnings Call
Feb 26 2026
seekingalpha
Collegium Pharmaceutical Reports Q4 Profit Growth
Feb 26 2026
NASDAQ.COM
Collegium Pharmaceutical Reaffirms 2026 Financial Guidance Amid Q4 Miss
Feb 26 2026
seekingalpha
Collegium Pharmaceutical to Announce Q4 Earnings on February 26
Feb 25 2026
seekingalpha
Collegium Pharmaceutical EVP Scott Dreyer Sells 17,600 Shares for ~$847,800
Jan 14 2026
Fool
Collegium Pharmaceutical EVP Dreyer Sells 17,600 Shares for ~$847,800
Jan 14 2026
NASDAQ.COM
Collegium Projects 2026 Product Revenues Between $805 Million and $825 Million
Jan 08 2026
Globenewswire
Collegium Pharmaceutical Closes $980 Million Credit Facility, Enhancing Debt Structure
Dec 30 2025
Globenewswire
Collegium Pharmaceutical Closes $980 Million Credit Facility, Enhancing Debt Structure
Dec 30 2025
Newsfilter
Top Value Stocks to Consider Purchasing on December 18
Dec 18 2025
NASDAQ.COM
Ensign Group Strengthens Presence in Three U.S. States Through Facility Acquisitions
Dec 03 2025
NASDAQ.COM
Stock of the Day: Collegium Pharmaceutical (COLL)
Nov 19 2025
NASDAQ.COM
Collegium Pharmaceutical Achieves Analyst Price Target
Nov 13 2025
NASDAQ.COM
Truist Securities Reaffirms Buy Rating for Collegium Pharmaceutical and Increases Price Target to $48
Nov 07 2025
Benzinga
Inaugural Week of COLL June 2026 Options Trading
Nov 07 2025
NASDAQ.COM
Collegium Pharmaceutical Stock Jumps 12% Following Q3 Results and Increased Guidance
Nov 06 2025
NASDAQ.COM
Show More News
